Skip to main content
. Author manuscript; available in PMC: 2011 Jul 12.
Published in final edited form as: Crit Rev Immunol. 2006;26(4):317–352. doi: 10.1615/critrevimmunol.v26.i4.30

Table I.

Mycobacterial antigens recognized by human CD8+ T cells

Antigena Rv numberb Restrictionc Epitoped Sequencee Frequencyf Ref
CFP10 Rv3874 a) HLA-B14 a) CFP1085–94 a) RADEEQQQAL a) 1/2,100h; LTBIk (22)
b) HLA-B44 b) CFP102–11 b) AEMKTDAATL b) 1/700h; LTBI
CFP10 Rv3874 a) HLA-A*02 a) CFP1076–85 a) IRQAGVQYSR ND (147)
b) HLA-B*35 b) CFP1071–79 b) EISTNIRQA
ESAT6 Rv3875 a) HLA-A2 a) ESAT682–90 a) AMASTEGNV a) 1/50,000h; TB (19)
b) HLA-B52 b) ESAT669–76 b) LQNLARTI b) 1/23,000h; TB
ESAT6 Rv3875 HLA-A68.02 ESAT621–29 NVTSIHSLL 1/2,500h; LTBI (148)
Ag85A Rv3804c HLA-A2 a) Ag85A48–56 a) GLPVEYLQV a) 1/3,500g,i; BCG (108)
b) Ag85A242–250 a) KLIANNTRV b) 1/3,500g,i; BCG
Ag85B Rv1886c HLA-A2 a) Ag85B143–152 a) FIYAGSLSAL ND (109)
b) Ag85B126–135 b) SMAGSSAMIL
c) Ag85B199–207 c) KLVANNTRL
d) Ag85B158–166 d) GMGPSLIGL
Ag85B Rv1886c HLA-A*0201 Ag85B15–23 LMIGTAAAV ND (196)
Ag85C Rv0129c HLA-B*3501 Ag85C204–212 WPTIIGLAM 1/13,700–22,222h; BCG (110)
Ag85ABC HLA-B*35 Ag85A110–118 MPVGGQSSF ND (110)
19 kDa Rv3763 HLA-A*0201 19 kDa88–97 VLTDGNPPEV ND (18)
19 kDa Rv3763 HLA-A*0201 19 kDa88–97 VLTDGNPPEV 1/123–769g,i (153)
16 kDa Rv2031c HLA-A*0201 a) 16-kDa21–29 a) LFAAFPSFA ~ 1/1000g,j; TB (156)
b) 16-kDa120–128 b) GILTVSVA
SodA Rv3846 HLA-A2 SodA160–168 DMWEHAFYL ND (227)
AlaDH Rv0512 HLA-A2 AlaDH160–169 VLMGGVPGVE ND (227)
GlnS Rv2220 HLA-A2 GlnS308–316 GLLHHAPSL ND (227)
Mtb39 Rv1196 HLA-B44 a) Mtb39144–153 a) MWAQDAAAMF ND (116)
b) Mtb39346–355 b) AAERGPGQML
ThyA Rv2764c HLA-A*0201 ThyA30–38 RLPLVLPAV ND (196)
PstA1 Rv0930 HLA-A*0201 PstA175–83 SLYFGGICV ND (196)
Hbha Rv0475 ND ND ND ND (182)
a

Common name for antigen.

b

The Rv designation for the mycobacterial protein.

c

The restricting MHC protein and allele, if known.

d

The location of the epitope within protein sequence.

e

The amino acid sequence of the epitope.

f

The frequency of antigen-specific T cells in PBMC unless otherwise stated.

g

The frequency of antigen-specific T cells among CD8+ T cells.

h

Determined using an Elispot assay.

i

Determined by flow cytometric analysis using peptide-loaded class I MHC-tetramers.

j

Determined by flow cytometric analysis using intracellular cytokine staining.

k

Infection status of subjects: LTBI, latent tuberculosis infection; TB, active tuberculosis; BCG, BCG vaccinated.

ND, not determined